Related Experiment Video
Updated: Jun 20, 2026
10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Hope in early-stage dementia: a concept analysis
1Drexel University College of Nursing and Health Professions and University of Pennsylvania School of Nursing, Philadelphia, PA 19104, USA. cottervt@nursing.upenn.edu
Holistic Nursing Practice
|August 29, 2009
Summary
Hope is crucial for early-stage dementia adjustment, aiding in maintaining normalcy and confidence. A supportive social network and helping others positively impact daily adaptation and self-concept preservation.
Area of Science:
- Gerontology
- Psychology
- Nursing
Background:
- Early-stage dementia presents challenges to maintaining normalcy and self-concept.
- Hope plays a vital role in the adjustment process for individuals with dementia.
- Understanding the dynamics of hope is essential for effective care.
Observation:
- Hope facilitates the development of cognitive, social, and behavioral strategies.
- Maintaining hope is linked to improved confidence and adaptation to daily living.
- Social support and altruism (helping others) are key components of the hope experience.
Findings:
- Walker and Avant's concept analysis method was used to explore hope in early-stage dementia.
- Key dynamics and components of the hope experience were identified.
- Hope is integral to preserving self-concept and adapting to life with dementia.
Implications:
- Healthcare professionals can use this understanding to support hope in dementia patients.
- Family caregivers can be guided to foster hope and strengthen self-concept in loved ones.
- Interventions focused on hope may improve quality of life for those with early-stage dementia.
Related Concept Videos
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...